Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Investment Summary

Market Valuation
Overvalued
Consensus
Skip
Best For

How This Company Makes Money

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Business Quality Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

MaxDividends Quality Score

Business Quality Score
Dividend Score

Sales Growth APLS

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin APLS

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income APLS

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM APLS

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio APLS

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

Apellis Pharmaceuticals Inc APLS

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Itself APLS

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE 38.35
Forward PE 46.30
Enterprise Value Revenue 4.82
Price Sales TTM 4.75
Enterprise Value EBITDA 29.55
Price Book MRQ 12.66

Bottom Line

Apellis Pharmaceuticals Inc

APLS
Current price
3.36 USD 0 USD (0.00%)
Last closed 3.37 USD
ISIN US03753U1060
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 5 252 712 960 USD
Yield for 12 month -85.90 %
1Y
3Y
5Y
10Y
15Y
APLS
11/21/2021 - 11/28/2021

Advanced Highlights

Current Year

+1 003 782 000 USD

Last Year

+781 367 000 USD

Current Quarter

+268 295 000 USD

Last Quarter

+199 913 000 USD

Current Year

+901 546 000 USD

Last Year

+663 644 000 USD

Current Quarter

+227 457 000 USD

Last Quarter

+170 194 000 USD
EBITDA 166 624 992 USD
Operating Margin TTM 9.87 %
Price to Earnings 38.35
Return On Assets TTM 10.93 %
PEG Ratio
Return On Equity TTM 46.02 %
Wall Street Target Price 40.92 USD
Revenue TTM 1 105 280 000 USD
Book Value 3.24 USD
Revenue Per Share TTM 8.72 USD
Dividend Share
Quarterly Revenue Growth YOY 60.90 %
Dividend Yield
Gross Profit TTM 710 465 024 USD
Earnings Per Share 1.07 USD
Diluted EPS TTM 1.07 USD
Most Recent Quarter I 2026
Quarterly Earnings Growth YOY
Profit Margin 12.06 %
Price to Free Cash Flow TTM 11.40

Technical Indicators APLS

For 52 Weeks

3.05 USD 41.14 USD
50 Day MA 33.60 USD
Shares Short Prior Month 14 239 228
200 Day MA 26.15 USD
Short Ratio 1.15
Shares Short 10 752 810
Short Percent 12.55 %